期刊文献+

尼可刹米结合无创正压通气对慢性阻塞性肺疾病急性加重期伴呼吸衰竭患者动脉血气指标的影响 被引量:3

Effect of nikethamide combined with noninvasive positive pressure ventilation on arterial blood gas indexes in patients with acute exacerbation of chronic obstructive pulmonary disease with respiratory failure
原文传递
导出
摘要 目的探讨针对慢性阻塞性肺疾病(COPD)急性加重期伴呼吸衰竭患者采取尼可刹米结合无创正压通气治疗对其动脉血气指标的影响。方法采用随机数表法将本院2017年10月—2019年10月收治的83例COPD急性加重期伴呼吸衰竭患者分为对照组42例、观察组41例。对照组予以尼可刹米治疗,观察组在对照组基础上结合无创正压通气联合治疗。对比分析2组临床疗效、1秒用力呼气量(FEV_(1))、用力肺活量(FVC)、1秒用力呼气量/用力肺活量比值(FEV_(1)/FVC)、动脉氧分压(PaO_(2))、动脉二氧化碳分压(PaCO_(2))及动脉血氧饱和度(SaO_(2))。结果观察组治疗总有效率92.68%,较对照组(69.05%)高(χ^(2)=7.448,P=0.006);观察组治疗后FVC(2.16±0.27)L、FEV_(1)(2.94±0.36)L、FEV_(1)/FVC(55.39±4.22)%,均高于对照组的(1.64±0.29)L、(2.27±0.43)L、(49.71±4.39)%,差异均有统计学意义(P<0.01);观察组治疗后PaO_(2)(90.73±7.11)mmHg、SaO_(2)(93.13±5.75)%,均高于对照组的(86.42±7.20)mmHg、(87.10±6.12)%,且PaCO_(2)(41.14±5.17)mmHg,低于对照组的(48.89±5.22)mmHg,差异均有统计学意义(P<0.01)。结论针对COPD急性加重期伴呼吸衰竭患者采取尼可刹米结合无创正压通气治疗,能够有效改善患者肺功能,调节动脉血气指标,值得推广。 Objective To investigate the effect of nikethamide combined with noninvasive positive pressure ventilation on arterial blood gas indexes in patients with acute exacerbation of chronic obstructive pulmonary disease(COPD)with respiratory failure.Methods A total of 83 patients with acute exacerbation of COPD with respiratory failure admitted to a hospital from October 2017 to October 2019 were randomly divided into a control group(42 cases)and an observation group(41 cases).The control group was treated with nikethamide,and the observation group was treated with the noninvasive positive pressure ventilation on the basis of the control group.The clinical efficacy,forced expiratory volume(FEV_(1)),forced vital capacity(FVC),FEV_(1)/FVC,arterial oxygen partial pressure(Pa O_(2)),arterial carbon dioxide partial pressure(Pa CO_(2))and arterial oxygen saturation(Sa O_(2))were investigated,analyzed and compared.Results The total effective rate of was 92.68%in the observation group,which was higher than that in the control group(69.05%),and the difference was statistically significant(χ^(2)=7.448,P=0.006).After the treatment,FVC[(2.16±0.27)L],FEV_(1)[(2.94±0.36)L]and FEV_(1)/FVC[(55.39±4.22)%]in the observation group were higher than those in the control group[(1.64±0.29)L,(2.27±0.43)L and(49.71±4.39)%],with statistically significant differences(P<0.01).After the treatment,the indexes of Pa O_(2)[(90.73±7.11)mm Hg]and Sa O_(2)[(93.13±5.75)%]in the observation group were higher than those in the control group[(86.42±7.20)mm Hg and(87.10±6.12)%],and Pa CO_(2)[(41.14±5.17)mm Hg]was lower than that in the control group[(48.89±5.22)mm Hg],with a statistically significant difference(P<0.01).Conclusion The treatment of nikethamide combined with noninvasive positive pressure ventilation in patients with acute exacerbation of COPD with respiratory failure can effectively improve the pulmonary function and regulate arterial blood gas indexes,which is worthy of promotion.
作者 邱亚林 QIU Ya-lin(Emergency Department,Central Hospital of Sanmenxia City,Sanmenxia 472000,Henan,China)
出处 《中国校医》 2021年第5期354-356,共3页 Chinese Journal of School Doctor
关键词 肺疾病 慢性阻塞性 急性加重期 血气分析 pulmonary disease,chronic obstruc-tive acute exacerbation blood gas analysis
  • 相关文献

参考文献15

二级参考文献159

共引文献2737

同被引文献39

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部